Unknown

Dataset Information

0

American College of Rheumatology Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents With Childhood-Onset Systemic Lupus Erythematosus.


ABSTRACT: OBJECTIVE:To develop a Childhood Lupus Improvement Index (CHILI) as a tool to measure response to therapy in childhood-onset systemic lupus erythematosus (cSLE), with a focus on clinically relevant improvement (CRIc SLE ). METHODS:Pediatric nephrology and rheumatology subspecialists (n = 213) experienced in cSLE management were invited to define CRIc SLE and rate a total of 433 unique patient profiles for the presence/absence of CRIc SLE . Patient profiles included the following cSLE core response variables (CRVs): global assessment of patient well-being (patient-global), physician assessment of cSLE activity (MD-global), disease activity index score (here, we used the Systemic Lupus Erythematosus Disease Activity Index), urine protein-to-creatinine ratio, and Child Health Questionnaire physical summary score. Percentage and absolute changes in these cSLE-CRVs (baseline versus follow-up) were considered in order to develop candidate algorithms and validate their performance (sensitivity, specificity, area under the receiver operating characteristic curve [AUC]; range 0-1). RESULTS:During an international consensus conference, unanimous agreement on a definition of CRIc SLE was achieved; cSLE experts (n = 13) concurred (100%) that the preferred CHILI algorithm considers absolute changes in the cSLE-CRVs. After transformation to a range of 0-100, a CHILI score of ?54 had outstanding accuracy for identifying CRIc SLE (AUC 0.93, sensitivity 81.1%, and specificity 84.2%). CHILI scores also reflect minor, moderate, and major improvement for values exceeding 15, 68, and 92, respectively (all AUC ?0.92, sensitivity ?93.1%, and specificity ?73.4%). CONCLUSION:The CHILI is a new, seemingly highly accurate index for measuring CRI in cSLE over time. This index is useful to categorize the degree of response to therapy in children and adolescents with cSLE.

SUBMITTER: Brunner HI 

PROVIDER: S-EPMC6483875 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Objective</h4>To develop a Childhood Lupus Improvement Index (CHILI) as a tool to measure response to therapy in childhood-onset systemic lupus erythematosus (cSLE), with a focus on clinically relevant improvement (CRI<sub>c</sub> <sub>SLE</sub> ).<h4>Methods</h4>Pediatric nephrology and rheumatology subspecialists (n = 213) experienced in cSLE management were invited to define CRI<sub>c</sub> <sub>SLE</sub> and rate a total of 433 unique patient profiles for the presence/absence of CRI<sub>  ...[more]

Similar Datasets

| S-EPMC6827566 | biostudies-literature
| S-EPMC3298664 | biostudies-literature
| S-EPMC6972605 | biostudies-literature
| S-EPMC11319914 | biostudies-literature
| S-EPMC6251621 | biostudies-literature
| S-EPMC4818571 | biostudies-literature
| S-EPMC4826472 | biostudies-literature
| S-EPMC10189815 | biostudies-literature
| S-EPMC4566153 | biostudies-literature
| S-EPMC5550018 | biostudies-other